
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Daruharidra (Berberis aristata) is an Ayurvedic herb containing berberine as its primary bioactive alkaloid. It works by inhibiting bacterial growth, reducing inflammation through NF-κB pathway modulation, and enhancing liver detoxification enzymes.

Reported Benefits (Provisional)
Origin & History

Daruharidra, or Berberis aristata, is a shrub native to the Himalayas. Its roots and stem bark are used in traditional medicine for their therapeutic properties.
Research Narrative (Provisional)
Some studies have demonstrated Daruharidra's potential anti-inflammatory and antimicrobial effects. However, more extensive clinical trials are needed to confirm these benefits.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Daruharidra (Berberis aristata) is primarily valued for its bioactive alkaloid content rather than conventional macronutrient density. Key bioactive compounds include: Berberine (primary alkaloid, 2–5% concentration in stem bark and roots, up to 3.2% in dried root extract), Berbamine (0.3–0.8%), Oxyberberine (0.1–0.4%), Palmatine (0.2–0.6%), Jatrorrhizine (0.1–0.3%), and Columbamine (trace amounts). Secondary metabolites include tannins (approximately 4–8% in bark), resinous matter (~3%), and starch. Micronutrient profile includes moderate levels of calcium (~180–220 mg/100g dried bark), iron (~6–9 mg/100g), zinc (~1.5–2.5 mg/100g), and magnesium (~85–110 mg/100g). Vitamin content is limited but includes small quantities of Vitamin C (~8–15 mg/100g) and B-complex traces. Dietary fiber content in powdered bark is approximately 12–18% (dry weight basis). Protein content is low at 4–7% dry weight. Fat content is negligible (<1%). Bioavailability notes: Berberine has inherently poor oral bioavailability (~5% absorption) due to P-glycoprotein efflux; co-administration with bioavailability enhancers like piperine significantly improves absorption. Alkaloid content varies substantially based on plant part used (roots > stem bark > leaves), geographical origin, and season of harvest.
Reported Mechanism (Provisional)
Berberine, the primary alkaloid in Daruharidra, inhibits the NF-κB inflammatory pathway and activates AMPK for metabolic regulation. It enhances bile acid synthesis through FXR receptor activation and exhibits antimicrobial activity by disrupting bacterial cell wall synthesis. The herb's isoquinoline alkaloids also support Phase II liver detoxification enzymes.
Clinical Narrative (Provisional)
Limited clinical studies exist specifically for Berberis aristata, though berberine research shows promise. Small trials (20-50 participants) suggest benefits for digestive complaints and skin conditions when used topically. Most evidence comes from traditional use studies and in vitro research on berberine content. Higher-quality human trials are needed to confirm therapeutic efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







